Clinical trials
Phase 1 Hepatoblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 3 |
| Seattle Children's Hospital | 3 |
| Baylor College of Medicine | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Bayer | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| New York Medical College | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatoblastoma | 17 |
| Rhabdomyosarcoma | 12 |
| Wilms Tumor | 12 |
| Neuroblastoma | 11 |
| Sarcoma, Ewing | 10 |
| Rhabdoid Tumor | 9 |
| Neoplasms, Germ Cell and Embryonal | 8 |
| Sarcoma | 8 |
| Osteosarcoma | 6 |
| Retinoblastoma | 6 |
Trials
Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.